Prevalence and prognostic impact of bundle branch block in patients with heart failure: Evidence from the CHARM programme
暂无分享,去创建一个
M. Pfeffer | S. Yusuf | J. McMurray | K. Swedberg | S. Pocock | C. Granger | E. Michelson | Duolao Wang | N. Hawkins | F. Dunn | J. Östergren
[1] Nick Freemantle,et al. Prevalence of ECG abnormalities in an international survey of patients with suspected or confirmed heart failure at death or discharge , 2007, European journal of heart failure.
[2] G. Weidinger,et al. Prognostic value of the QRS duration in patients with heart failure: a subgroup analysis from 24 centers of Val-HeFT. , 2005, Journal of cardiac failure.
[3] W. Weaver,et al. Bundle branch block patterns, age, renal dysfunction, and heart failure mortality. , 2005, International journal of cardiology.
[4] J. Daubert,et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.
[5] Y. Nose,et al. Prognostic significance of electrocardiographic findings in patients with dilated cardiomyopathy , 2005, Heart and Vessels.
[6] Jonathan M Doris,et al. Proportion of patients in a congestive heart failure care management program meeting criteria for cardiac resynchronization therapy. , 2004, The American journal of cardiology.
[7] M. Domanski,et al. Prevalence and predictors of heart failure with preserved systolic function: community hospital admissions of a racially and gender diverse elderly population. , 2004, Journal of cardiac failure.
[8] Karl Swedberg,et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial , 2003, The Lancet.
[9] Karl Swedberg,et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial , 2003, The Lancet.
[10] M. Pfeffer,et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial , 2003, The Lancet.
[11] M. Pfeffer,et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme , 2003, The Lancet.
[12] A. Maggioni,et al. Intraventricular conduction defects in patients with congestive heart failure: left but not right bundle branch block is an independent predictor of prognosis. A report from the Italian Network on Congestive Heart Failure (IN-CHF database). , 2003, Italian heart journal : official journal of the Italian Federation of Cardiology.
[13] M. Pfeffer,et al. Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure—Assessment of Reduction in Mortality and morbidity (CHARM) programme , 2003, European journal of heart failure.
[14] P. Varadarajan,et al. Prognosis of congestive heart failure in patients with normal versus reduced ejection fractions: results from a cohort of 2,258 hospitalized patients. , 2003, Journal of cardiac failure.
[15] S. Baldasseroni. P3228 Influence of body mass index and metabolic-inflammatory variables on prognosis of outpatients with chronic heart failure. Data from the Italian Network on Congestive Heart Failure (IN-CHF Registry) , 2003 .
[16] J. Steiner,et al. Gender, age, and heart failure with preserved left ventricular systolic function. , 2003, Journal of the American College of Cardiology.
[17] W. Grimm,et al. How Many Patients with Dilated Cardiomyopathy May Potentially Benefit from Cardiac Resynchronization Therapy? , 2003, Pacing and clinical electrophysiology : PACE.
[18] S. Silver,et al. Heart Failure , 1937, The New England journal of medicine.
[19] P. McCullough,et al. Congestive heart failure and QRS duration: establishing prognosis study. , 2002, Chest.
[20] Luigi Tavazzi,et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. , 2002, American heart journal.
[21] M. Das,et al. Prolonged QRS duration (QRS >/=170 ms) and left axis deviation in the presence of left bundle branch block: A marker of poor left ventricular systolic function? , 2001, American heart journal.
[22] J. Amin,et al. Prognostic implications of increased QRS duration in patients with moderate and severe left ventricular systolic dysfunction. , 2001, The American journal of cardiology.
[23] N. Patel,et al. How many people with heart failure are appropriate for biventricular resynchronization? , 2000, European heart journal.
[24] M. Pfeffer,et al. Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators. , 1999, Journal of cardiac failure.
[25] S. Anker,et al. Intraventricular conduction delay: a prognostic marker in chronic heart failure. , 1999, International journal of cardiology.
[26] J. Ornato,et al. Bundle-Branch Block and In-Hospital Mortality in Acute Myocardial Infarction , 1998, Annals of Internal Medicine.
[27] J. Ornato,et al. Bundle-branch block and in-hospital mortality in acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. , 1998, Annals of internal medicine.
[28] G S Wagner,et al. Acute myocardial infarction and complete bundle branch block at hospital admission: clinical characteristics and outcome in the thrombolytic era. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-type plasminogen activator] for Occluded Coronary Arteries. , 1998, Journal of the American College of Cardiology.
[29] D. Gibson,et al. Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy. , 1996, International journal of cardiology.
[30] W. Shen,et al. Clinical significance of complete left bundle branch block in dilated cardiomyopathy. , 1995, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.
[31] G. Critelli,et al. Resting and ambulatory ECG predictors of mode of death in dilated cardiomyopathy. , 1992, Journal of electrocardiology.
[32] R. Raddino,et al. [The prognosis of the patient with heart failure: an analysis of the most significant clinical and instrumental parameters]. , 1991, Cardiologia.